| Item 1. | |
| (a) | Name of issuer:
PRECISION BIOSCIENCES INC |
| (b) | Address of issuer's principal executive offices:
302 East Pettigrew St., Suite A-100, Durham, North Carolina, 27701 |
| Item 2. | |
| (a) | Name of person filing:
(i) Readout Capital, LP, (ii) Readout Capital GP, LLC, (iii) ROC Holdings SPV II, LP, (iv) Readout Holdings GP, LLC, and (v) Matthew Smith (collectively, the "Reporting Persons") |
| (b) | Address or principal business office or, if none, residence:
For each of the Reporting Persons: 1630 Columbia Road NW, Unit 418, Washington, D.C. 20009 |
| (c) | Citizenship:
(i) Readout Capital, LP is a Delaware limited partnership, (ii) Readout Capital GP, LLC is a Delaware limited liability company, (iii) ROC Holdings SPV II, LP is a Delaware limited partnership, (iv) Readout Holdings GP, LLC is a Delaware limited liability company and (v) Matthew Smith is a United States citizen. |
| (d) | Title of class of securities:
Common Stock, par value $0.000005 per share |
| (e) | CUSIP No.:
74019P207 |
| Item 3. | If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: |
| (a) |  Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
|
| (b) | Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
|
| (c) | Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
|
| (d) | Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
|
| (e) | An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
|
| (f) | An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
|
| (g) | A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
|
| (h) | A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
|
| (i) | A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
|
| (j) | A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
|
| (k) | Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
|
| | |
| Item 4. | Ownership |
| (a) | Amount beneficially owned:
The information in Item 9 of the cover pages of this Schedule 13G for each of the Reporting Persons, which is as June 30, 2025, is incorporated herein by reference. As of June 30, 2025, ROC Holdings SPV II, LP ("ROC SPV II") directly held 686,437 shares of Common Stock, par value $0.000005 per share ("Common Stock"), of Precision BioSciences, Inc. (the "Issuer") and warrants exercisable for 220,000 shares of Common Stock of the Issuer. Readout Holdings GP, LLC ("Readout Holdings GP") is the general partner of ROC SPV II and Readout Capital, LP ("Readout Capital") serves as investment manager for ROC SPV II. Readout Capital GP, LLC ("Readout Capital GP") is the general partner of Readout Capital and Matthew Smith is the Manager of each of Readout Holdings GP and Readout Capital GP. In addition, Readout Capital serves as the investment manager for a managed account that as of June 30, 2025, held 200,000 shares of Common Stock of the Issuer, and Readout Capital has been delegated voting and investment power over shares of Common Stock held by such managed account pursuant to an Investment Management Agreement. As of June 30, 2025, Matthew Smith directly held 12,874 shares of Common Stock of the Issuer. |
| (b) | Percent of class:
As of June 30, 2025, each of Readout Capital and Readout Capital GP may have been deemed to have beneficially owned 9.3% of the shares of Common Stock of the Issuer outstanding. As of June 30, 2025, each of ROC SPV II and Readout Holdings GP may have been deemed to have beneficially owned 7.6% of the shares of Common Stock of the Issuer outstanding. As of June 30, 2025, Matthew Smith may have been deemed to have beneficially owned 9.4% of the shares of Common Stock of the Issuer outstanding. Such percentages are based on 11,636,981 shares of Common Stock of the Issuer outstanding as of June 30, 2025, as disclosed in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on August 7, 2025, plus 220,000 shares of Common Stock issuable upon exercise of warrants directly held by ROC SPV II as of June 30, 2025. |
| (c) | Number of shares as to which the person has:
|
| | (i) Sole power to vote or to direct the vote:
As of June 30, 2025, each of Readout Capital and Readout Capital GP may have been deemed to have had sole power to vote or to direct the vote of 200,000 shares of Common Stock. As of June 30, 2025, each of ROC SPV II and Readout Holdings GP may have been deemed to have had sole power to vote or direct the vote of 0 shares of Common Stock. As of June 30, 2025, Matthew Smith may have been deemed to have had sole power to vote or to direct the vote of 212,874 shares of Common Stock.
|
| | (ii) Shared power to vote or to direct the vote:
As of June 30, 2025, each of Readout Capital and Readout Capital GP may have been deemed to have had shared power to vote or to direct the vote of 906,437 shares of Common Stock, which amount includes 220,000 shares of Common Stock issuable upon exercise of warrants directly held by ROC SPV II as of June 30, 2025. As of June 30, 2025, each of ROC SPV II and Readout Holdings GP may have been deemed to have had shared power to vote or direct the vote of 906,437 shares of Common Stock, which amount includes 220,000 shares of Common Stock issuable upon exercise of warrants directly held by ROC SPV II as of June 30, 2025. As of June 30, 2025, Matthew Smith may have been deemed to have had shared power to vote or to direct the vote of 906,437 shares of Common Stock, which amount includes 220,000 shares of Common Stock issuable upon exercise of warrants directly held by ROC SPV II as of June 30, 2025.
|
| | (iii) Sole power to dispose or to direct the disposition of:
As of June 30, 2025, each of Readout Capital and Readout Capital GP may have been deemed to have had sole power to dispose or to direct the disposition of 200,000 shares of Common Stock. As of June 30, 2025, each of ROC SPV II and Readout Holdings GP may have been deemed to have had sole power to dispose or direct the disposition of 0 shares of Common Stock. As of June 30, 2025, Matthew Smith may have been deemed to have had sole power to dispose or to direct the disposition of 212,874 shares of Common Stock.
|
| | (iv) Shared power to dispose or to direct the disposition of:
As of June 30, 2025, each of Readout Capital and Readout Capital GP may have been deemed to have had shared power to dispose or to direct the disposition of 906,437 shares of Common Stock, which amount includes 220,000 shares of Common Stock issuable upon exercise of warrants directly held by ROC SPV II as of June 30, 2025. As of June 30, 2025, each of ROC SPV II and Readout Holdings GP may have been deemed to have had shared power to dispose or direct the disposition of 906,437 shares of Common Stock, which amount includes 220,000 shares of Common Stock issuable upon exercise of warrants directly held by ROC SPV II as of June 30, 2025. As of June 30, 2025, Matthew Smith may have been deemed to have had shared power to dispose or to direct the disposition of 906,437 shares of Common Stock, which amount includes 220,000 shares of Common Stock issuable upon exercise of warrants directly held by ROC SPV II as of June 30, 2025.
|
| Item 5. | Ownership of 5 Percent or Less of a Class. |
| | |
| Item 6. | Ownership of more than 5 Percent on Behalf of Another Person. |
| |
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
The information in Item 4 is incorporated herein by reference. |
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. |
| |
Not Applicable
|
| Item 8. | Identification and Classification of Members of the Group. |
| |
Not Applicable
|
| Item 9. | Notice of Dissolution of Group. |
| |
Not Applicable
|
Rule 13d-1(c)